Coagulopathy in COVID-19: Which challenges do we face in the area of Coagulation.
SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
Systemic coagulation activation and thrombotic complications, such as venous thromboembolism, emerged as an important consideration in the management of patients.
Experts around the globe are heavily seeking to understand the pathophysiological aspects and to provide guidance in therapy.
In this webinar, which will focus entirely on topics related to the field of Coagulation,
SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.